Eren, T. Et Al. 2020. Efficacy of the Combination of Modified Docetaxel, Cisplatin and Fluorouracil in Locally Advanced Gastric Cancer: Evaluation of Real-Life Outcomes. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.30, no.1 , 23-31.

Eren, T., Karacin, C., Ucar, G., Ergun, Y., YAZICI, O., Imamoglu, G. I., ... Bostanci, B.(2020). Efficacy of the Combination of Modified Docetaxel, Cisplatin and Fluorouracil in Locally Advanced Gastric Cancer: Evaluation of Real-Life Outcomes. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.30, no.1, 23-31.

Eren, Tulay Et Al. "Efficacy of the Combination of Modified Docetaxel, Cisplatin and Fluorouracil in Locally Advanced Gastric Cancer: Evaluation of Real-Life Outcomes," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.30, no.1, 23-31, 2020

Eren, Tulay Et Al. "Efficacy of the Combination of Modified Docetaxel, Cisplatin and Fluorouracil in Locally Advanced Gastric Cancer: Evaluation of Real-Life Outcomes." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.30, no.1, pp.23-31, 2020

Eren, T. Et Al. (2020) . "Efficacy of the Combination of Modified Docetaxel, Cisplatin and Fluorouracil in Locally Advanced Gastric Cancer: Evaluation of Real-Life Outcomes." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.30, no.1, pp.23-31.

@article{article, author={Tulay Eren Et Al. }, title={Efficacy of the Combination of Modified Docetaxel, Cisplatin and Fluorouracil in Locally Advanced Gastric Cancer: Evaluation of Real-Life Outcomes}, journal={UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI}, year=2020, pages={23-31} }